Kinnate Biopharma Inc.
KNTE
Revenue
0.00
0.000.00%
-Assets
173.61M
▼-17.10M▼-8.97%
3 Months ChangeLiabilities
14.28M
▼-4.01M▼-21.93%
3 Months ChangeFree Cash Flow
-27.73M
▼-4.63M▼-20.02%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-04-03
Form 8-K
ID: 0001193125-24-085548
2024-03-01
Form 8-K
ID: 0001140361-24-010648
2024-02-16
Form 8-K
ID: 0001140361-24-008282
2024-01-16
Form 8-K
ID: 0001140361-24-002334
2023-11-22
Form 8-K
ID: 0001140361-23-054438
2023-11-15
Form 8-K
ID: 0001140361-23-053357
2023-11-09
Form 10-Q
ID: 0001140361-23-052465
2023-11-09
Form 8-K
ID: 0001140361-23-052459
2023-09-18
Form 8-K
ID: 0001140361-23-044353
2023-08-08
Form 10-Q
ID: 0001140361-23-038597